Oramed Submits Protocol To US FDA For Phase11B Oral Insulin By: Benzinga via Benzinga May 26, 2015 at 08:17 AM EDT Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development ... Read More >> Related Stocks: Oramed Pharma